Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age.


Journal

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
ISSN: 1873-5010
Titre abrégé: J Cyst Fibros
Pays: Netherlands
ID NLM: 101128966

Informations de publication

Date de publication:
07 2019
Historique:
received: 03 04 2018
revised: 05 08 2018
accepted: 12 10 2018
pubmed: 28 10 2018
medline: 18 9 2020
entrez: 28 10 2018
Statut: ppublish

Résumé

The causes of subfertility in women with CF though multifactorial are not well described. Our aim in this study was to determine the prevalence and factors associated with female subfertility among women with CF. A retrospective multinational study from 11 CF centers in 5 countries (Israel, France, Spain, Italy, UK) including women with CF was undertaken. Sub/infertility was defined as not achieving a spontaneous pregnancy after one year of unprotected sexual intercourse. Data including genetics, pancreatic insufficiency (PI), prevalence of diabetes (CFRD), lung function, nutritional status measured by body mass index (BMI), sputum bacterial colonization, and rate of pulmonary exacerbations were collected from patients' files. Out of 605 women, 241 attempted pregnancy. Of these, 84 (35%) had subfertility, and 67 of them eventually became pregnant. Females attempting conception were older but had better pulmonary function and nutrition compared to those who did not. In a multivariate analysis, PI (OR 1.9 [1.03-3.5], p = .04) and older age (OR 3.9 [2.1-7.3] p < .0001) were associated with subfertility. Lung function, BMI, CFRD, Presence of two class I-III mutations and number of exacerbations in the year prior to fertility attempts were not associated with subfertility. The prevalence of subfertility among women with CF (35%) is higher than the expected 5-15% subfertility in the general population. Older age and pancreatic insufficiency are associated with subfertility in women with CF.

Identifiants

pubmed: 30366850
pii: S1569-1993(18)30867-1
doi: 10.1016/j.jcf.2018.10.009
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

525-529

Informations de copyright

Copyright © 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Auteurs

Michal Shteinberg (M)

Pulmonology Institute, Carmel Medical Center, Israel; Cystic Fibrosis Center, Carmel Medical Center, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, Israel. Electronic address: michalsh@technion.ac.il.

Adi Ben Lulu (AB)

Pulmonology Institute, Carmel Medical Center, Israel; Cystic Fibrosis Center, Carmel Medical Center, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, Israel.

Damian G Downey (DG)

Center for Experimental Medicine, Queens University Belfast, , Belfast, UK; Northern Ireland Regional Adult Cystic Fibrosis Center, Belfast Health and Social Care Trust, Belfast, UK.

Zeev Blumenfeld (Z)

Ruth and Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, Israel; Women Health Center, Meuhedet, Haifa, Israel.

Christine Rousset-Jablonski (C)

Cystic Fibrosis Center, Groupement Hospitalier Sud Hospices Civils de Lyon, Lyon, France.

Marie Perceval (M)

Cystic Fibrosis Center, Groupement Hospitalier Sud Hospices Civils de Lyon, Lyon, France.

Alessandra Colombo (A)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy.

Nili Stein (N)

Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.

Galit Livnat (G)

Cystic Fibrosis Center, Carmel Medical Center, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, Israel.

Michal Gur (M)

Ruth and Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, Israel; Cystic Fibrosis Center, Rambam Medical Center, Haifa, Israel.

Lea Bentur (L)

Ruth and Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, Israel; Cystic Fibrosis Center, Rambam Medical Center, Haifa, Israel.

Huda Mussaffi (H)

Kathy and Lee Graub Cystic Fibrosis Center, Schneider Children's Medical Center of Israel, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Hannah Blau (H)

Kathy and Lee Graub Cystic Fibrosis Center, Schneider Children's Medical Center of Israel, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ifat Sarouk (I)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Cystic Fibrosis Center, Sheba Medical Center, Tel Aviv, Israel.

Adi Dagan (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Cystic Fibrosis Center, Sheba Medical Center, Tel Aviv, Israel.

Eitan Kerem (E)

Cystic Fibrosis Center, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Micha Aviram (M)

Cystic Fibrosis Center, Soroka Medical Center, Beersheva, Israel.

Elie Picard (E)

Cystic Fibrosis Center, Shaare Zedek Medical Center, Jerusalem, Israel.

Stefano Aliberti (S)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy.

Antonio Álvarez (A)

Adult CF Center, Hospital Universitari Vall d'Hebron- VHIR, Barcelona, Spain.

Javier Perez Miranda (JP)

Adult CF Center, Hospital Universitari Vall d'Hebron- VHIR, Barcelona, Spain.

Eva Polverino (E)

Adult CF Center, Hospital Universitari Vall d'Hebron- VHIR, Barcelona, Spain.

Isabelle Durieu (I)

Cystic Fibrosis Center, Groupement Hospitalier Sud Hospices Civils de Lyon, Lyon, France.

J Stuart Elborn (J)

Center for Experimental Medicine, Queens University Belfast, , Belfast, UK; Northern Ireland Regional Adult Cystic Fibrosis Center, Belfast Health and Social Care Trust, Belfast, UK.

Malena Cohen-Cymberknoh (M)

Cystic Fibrosis Center, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH